Vitamin D Nutritional Status and Infectious Diseases
Received Date: Jan 19, 2018 / Accepted Date: Jan 30, 2018 / Published Date: Feb 05, 2018
Keywords: Hypovitaminosis; Vitamin D; Nutrition
Hypovitaminosis D is highly prevalent worldwide . Vitamin D importance is well known in bone diseases, but its role in infectious diseases has been recognised recently . The main source of vitamin D is endogenous production in the skin under the influence of sun light. In the liver all vitamin D is hydroxylated to 25 hydroxyvitamin D (25OHD), which is the major circulating form of vitamin D, so serum levels of 25OHD are considered the best marker of nutritional vitamin D status. Under the control of feedback mechanisms 25OHD is hydroxylated in the kidney to the circulating hormone 1,25 (OH)2 D (calcitriol). Circulating calcitriol regulates calcium metabolism (“classical endocrine pathway of vitamin D”).
However, other cells can also synthetize calcitriol from circulating 25OHD after the activation of Toll like receptors by pathogenassociated molecular patterns of infectious agents (“non-classical intracrine/paracrine pathway”), independently of the calcium regulatory hormones [2,3]. Calcitriol activates its nuclear receptor (VDR) and so boosts innate immunity inducing increased secretion of antimicrobial peptides, such as cathelicidin (also known as LL-37) and B-defensin 2 in barrier cells (skin, respiratory tract, etc) and macrophages. Vitamin D-dependent antimicrobials belong to a group of evolutionary primitive, multifunctional cationic peptides that potentiate autophagy, destroy bacteria, fungus and virus and can induce other actions such as quimiotaxis, etc. . Minimal serum levels of 25OHD for normal bone metabolism are 20 ng/ml . These cut-off values are, however, controversial .
Although it has been demonstrated a high prevalence of hypovitaminosis D in infectious (mostly respiratory) diseases [4-8], it is difficult to establish if these changes are a cause or a consequence of the disease. Many respiratory infections are more prevalent in winter, when 25OHD levels are lower. On the other hand, 25OHD levels could be lowered by infectious diseases due to hyperconsumption of this metabolite.
Vitamin D supplementation used preventively or therapeutically for these conditions has been studied in many clinical trials and metaanalyses, with contradictory results , probably due to suboptimal quality of the studies, heterogeneous population, small number of patients, different doses and route of administration of vitamin D, and different clinical outcomes. Two recent meta-analyses of well-done clinical trials [9,10] conclude that vitamin D supplementation is safe and decreases the number of acute respiratory tract infections. Most benefit was found in patients with very severe vitamin D deficiency and in those not receiving bolus doses.
Infectious diseases are the cause of exacerbation of most chronic respiratory conditions. A meta-analysis of recent studies of supplementation with vitamin D has shown a decrease in number or symptoms of COPD exacerbations, especially in patients with severe vitamin D deficiency . Curiously vitamin D supplementation has also shown to ameliorate asthmatic exacerbations, probably due to its immunomodulatory functions . Up-to-now vitamin D supplementation as an add-on therapy for tuberculosis or pneumonia has not shown utility .
In conclusion, Vitamin D has an important role both in innate and adaptive inmunity. Hipovitaminosis D should be considered both in accute infectious diseases and in chronic diseases that predispose to infectious diseases.
- Bouillon R, van Schoor NM, Gielen E, Boonen S, Mathieu C, et al. (2013) Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 98:1283-1304.
- Amado CA, García-Unzueta MT, Fariñas MC, Amado JA (2016) Calcitriol-modulated human antibiotics: New pathophysiological aspects of vitamin D. Endocrinol Nutr 63: 87-94.
- Vanherwegen AS, Gysemans C, Mathieu C (2017) Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin North Am 46: 1061-1094.
- Ginde AA, Mansbach JM, Camargo Jr C (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Thirth National Health and Nutrition Examination Survey (NHANES III). Arch Intern Med 169: 384-390.
- Zhou J, Du J, Huang L, Wang Y, Shi Y, et al. (2018) Preventive effects of vitamin D on seasonal influenza A in infants: A multicentre, randomized, open-control clinical trial. Pediatr Infect Dis J.
- Chalmers JD, McHugh BJ, Docherty C, Govan JRW, Hill AT (2013) Vitamin D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Thorax 68: 39-47.
- Lowery EM, Bemiss B, Cascino T, Durazo-Arvizu RA, Forsythe SM, et al. (2012) Low vitamin D levels are associated with increased rejection and infections after lung transplantation. J Heart Lung Transpl 31: 700-707.
- Amado CA, García-Unzueta MT, Fariñas MC, Santos F, Ortiz M, et al. (2016) Vitamin D nutritional status and vitamin D regulated antimicrobial peptides in serum and pleural fluid of patients with infectious and noninfectious pleural effusions. BMC Pulm Med 16: 99.
- Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, et al. (2017) Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol 5: 986-1004.
- Martineau AR, Jolliffe DA, Hooper RL (2017) Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 356: i6583.
- Jolliffe DA, Greenberg L, Hopper RL, Griffiths CJ, Camargo CA Jr, et al. (2017) Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respir Med 11: 881-890.
Citation: Amado CA, Pérez MRI (2018) Vitamin D Nutritional Status and Infectious Diseases. J Infect Dis Ther 6: 349. Doi: 10.4172/2332-0877.1000349
Copyright: © 2018 Amado CA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
June 25-26, 2018 Vancouver, Canada
September 17-18, 2018 San Diego, USA
August 22-23, 2018 Tokyo, Japan
November 07-08, 2018 Alabama, USA
- Total views: 323
- [From(publication date): 0-2018 - May 28, 2018]
- Breakdown by view type
- HTML page views: 282
- PDF downloads: 41